The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...

Researchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended primary target. In a study recently published in the Clinical Immunology ...

and comprehensive preparedness," by focusing on "in-house development" of vaccines instead of projects from outside researchers. It is also planning to develop other vaccines for COVID-19 using ...

A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced its business update and financial results for the first quarter of ...

Rudman Spergel, MD, director of clinical development at Moderna ... the technology to create one of the world’s first COVID-19 vaccines. In 2023, the company announced results from a phase ...

The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...

HealthDay News — The US Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) announced a new initiative called “Generation Gold Standard” to develop ...

(CNN) — The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat that hasn’t been achieved for the past 45: the development of a ...

Trump halted biological research funding to adversaries such as China and Iran because of concerns COVID-19 originated in a ...

Messenger Ribonucleic Acid (mRNA) vaccines gained global recognition during the Coronavirus Disease 2019 (COVID-19) pandemic, proving their value through rapid development, high efficacy ...